Want to see CON full AI Analyst Report?
Top Page
Concentra Group Holdings Parent, Inc.
(NYSE:CON)
Select Model
Select Model
Rating:66Neutral
Price Target:
$33.00
▲(4.40% Upside)
Action:Reiterated
Date:08/07/26
Overall score reflects strong operating momentum and upbeat, raised guidance (growth, margin expansion, and improved cash generation), tempered primarily by balance-sheet leverage and reduced equity cushion. Technicals are mixed and valuation is reasonable but not cheap, providing a neutral-to-slightly-positive secondary backdrop.
Positive Factors
Top-line momentum
Sustained double-digit and TTM revenue growth reflects durable demand for occupational and onsite health services, expanding visit volumes and revenue-per-visit. This persistent top-line expansion supports scale advantages, reinvestment capacity, and gives management runway to reduce leverage over the next 2–6 months.
Negative Factors
High leverage & thinner equity cushion
Material debt growth and a shrunken equity base leave the company more sensitive to refinancing risk and earnings shocks. Elevated leverage constrains strategic flexibility, increases interest and covenant risk, and makes successful, sustained deleveraging a critical near-term requirement for financial stability.
Read all positive and negative factors
Positive Factors
Negative Factors
Top-line momentum
Sustained double-digit and TTM revenue growth reflects durable demand for occupational and onsite health services, expanding visit volumes and revenue-per-visit. This persistent top-line expansion supports scale advantages, reinvestment capacity, and gives management runway to reduce leverage over the next 2–6 months.
Read all positive factors
Concentra Group Holdings Parent, Inc. Key Performance Indicators (KPIs)
Any
Revenue By Segment
Allocates Concentra's revenue across its business lines—occupational health, urgent care, physical therapy, and related services—revealing which areas drive sales and where the company depends on employer contracts or payer mixes. Growth or margin expansion in higher-value segments points to scalable, profitable growth, while concentration or declines highlight exposure to contract loss, reimbursement cuts, or competitive risk.
Allocates Concentra's revenue across its business lines—occupational health, urgent care, physical therapy, and related services—revealing which areas drive sales and where the company depends on employer contracts or payer mixes. Growth or margin expansion in higher-value segments points to scalable, profitable growth, while concentration or declines highlight exposure to contract loss, reimbursement cuts, or competitive risk.
Data provided by:
The Fly
The FlyConcentra Group Holdings Parent, Inc. (CON) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$4.46B
Dividend Yield0.71%
Average Volume (3M)1.01M
Price to Earnings (P/E)22.6
Beta (1Y)0.57
Revenue Growth14.02%
EPS Growth31.92%
CountryUS
Employees9,983
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)1.55
Shares Outstanding127,517,740
10 Day Avg. Volume889,754
30 Day Avg. Volume1,008,042
Financial Highlights & Ratios
PEG Ratio2.05
Price to Book (P/B)6.34
Price to Sales (P/S)1.15
P/FCF Ratio12.65
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$40.71Price Target Upside28.80% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)1.63
Revenue Forecast (FY)$2.35B
Concentra Group Holdings Parent, Inc. Business Overview & Revenue Model
Company Description
Concentra Group Holdings Parent, Inc. is a U.S.-based provider of occupational health solutions. The company delivers a comprehensive suite of occupational and consumer health services, encompassing treatment for workers' compensation injuries, ur...
How the Company Makes Money
null...
Concentra Group Holdings Parent, Inc. Earnings Call Summary
Earnings Call Date:Aug 06, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Oct 29, 2026
Earnings Call Sentiment Positive
The call delivers a broadly positive message: robust top-line growth (10% revenue increase), notable margin expansion (EBITDA +22.5% and ~240 bps improvement), strong cash generation (operating cash flow and free cash flow roughly doubled YoY), successful acquisitions (Pivot/Nova ahead of underwriting), and updated, higher 2026 guidance. Manageable lowlights include comparability benefits from prior-year one-offs, expected moderation toward long-term visit growth, seasonality affecting margins, remaining debt/leveraging goals, and limited short-term contribution from new de novos. Overall, the strengths materially outweigh the risks and caveats discussed.Positive Updates
Revenue Growth
Total company revenue of $606.0M in Q2 2026, up 10.0% YoY; core revenue excluding Pivot was $589.1M, up 8.0% YoY.
Negative Updates
Comparability Noise from Prior-Year One-Time Items
Q2 2025 included ~ $4M of Nova acquisition-related integration costs and other one-time items; the removal of those costs provided a tailwind to 2026 comparables and margins, introducing some noise into YoY comparisons.
Read all updates
Q2-2026 Updates
Positive
Negative
Revenue Growth
Total company revenue of $606.0M in Q2 2026, up 10.0% YoY; core revenue excluding Pivot was $589.1M, up 8.0% YoY.
Read all positive updates
Company Guidance
Management raised 2026 guidance to revenue of $2.325–2.375 billion (low end +$50M), adjusted EBITDA of $485–495 million (low +$25M, high +$15M), and free cash flow of $220–240 million (both ends +$5M), with CapEx unchanged at $70–80 million. The upgrade follows a strong Q2: revenue $606.0M (+10% YoY; ex‑Pivot $589.1M, +8%), average visits >56,000/day (+2.6%), work‑comp visits +3.7%, employer‑services visits +1.8%, revenue per visit +4.6% (work comp +4.9%, employer services +3.2%), adjusted EBITDA $140.9M (+22.5% YoY) and margin 23.3% (+240 bps), adjusted net income $66.7M and adj. EPS $0.52 (~40% growth). Cash flow and balance‑sheet items noted: operating cash flow $135.2M, free cash flow $121M (vs $63.2M LY), investing cash use $14.2M, total debt $1.57B, cash $158M, net leverage just under 3x (from 3.4x) with a target near 2.5x, Term Loan B spread to step down 25 bps to 175 bps, ~$54M remaining repurchase capacity, and a $0.0625/share dividend payable Aug. 28.Concentra Group Holdings Parent, Inc. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
46
Neutral
Cash Flow
72
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.29B | 2.16B | 1.90B | 1.84B | 1.72B |
| Gross Profit | 670.56M | 613.09M | 527.98M | 512.43M | 408.19M |
| EBITDA | 459.77M | 408.93M | 368.26M | 360.15M | 330.20M |
| Net Income | 198.73M | 166.41M | 166.54M | 179.95M | 166.73M |
Balance Sheet | |||||
| Total Assets | 3.01B | 3.04B | 2.52B | 2.49B | 2.30B |
| Cash, Cash Equivalents and Short-Term Investments | 158.04M | 79.90M | 183.25M | 31.37M | 37.66M |
| Total Debt | 2.14B | 2.10B | 1.95B | 905.00M | 1.04B |
| Total Liabilities | 2.50B | 2.62B | 2.22B | 1.31B | 1.30B |
| Stockholders Equity | 477.10M | 393.28M | 275.67M | 1.16B | 973.32M |
Cash Flow | |||||
| Free Cash Flow | 349.75M | 197.06M | 210.35M | 164.98M | 228.35M |
| Operating Cash Flow | 335.55M | 279.40M | 274.68M | 234.32M | 274.34M |
| Investing Cash Flow | -69.64M | -414.86M | -71.27M | -75.31M | -57.75M |
| Financing Cash Flow | -181.74M | 32.10M | -51.53M | -165.29M | -209.86M |
Concentra Group Holdings Parent, Inc. Technical Analysis
Positive
31.61
Price Trends
31.57
Positive
27.69
Positive
24.41
Positive
Market Momentum
1.16
Negative
65.58
Neutral
69.41
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CON, the sentiment is Positive. The current price of 31.61 is below the 20-day moving average (MA) of 33.35, above the 50-day MA of 31.57, and above the 200-day MA of 24.41, indicating a bullish trend. The MACD of 1.16 indicates Negative momentum. The RSI at 65.58 is Neutral, neither overbought nor oversold. The STOCH value of 69.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CON.
Concentra Group Holdings Parent, Inc. Risk Analysis
Concentra Group Holdings Parent, Inc. disclosed 63 risk factors in its most recent earnings report. Concentra Group Holdings Parent, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Concentra Group Holdings Parent, Inc. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $27.28B | 27.88 | 11.57% | 0.97% | 6.41% | 33.31% | |
73 Outperform | $2.04B | 13.40 | 15.28% | 1.64% | ― | ― | |
66 Neutral | $4.46B | 22.57 | 47.30% | 0.79% | 14.02% | 31.92% | |
66 Neutral | $4.37B | 46.34 | 4.10% | ― | 11.89% | 85.76% | |
59 Neutral | $857.05M | -11.74 | -26.30% | ― | 52.54% | 2.69% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
39 Underperform | $109.35M | -6.88 | -107.61% | ― | 92.59% | 0.97% |
* General Sector Average
CON
Concentra Group Holdings Parent, Inc.
34.99
11.80
50.91%
LH
Labcorp Holdings
339.34
66.11
24.20%
NVST
Envista Holdings
27.34
6.22
29.45%
SPAI
Safe Pro Group, Inc.
5.37
-1.42
-20.91%
FLOC
Flowco Holdings Inc Class A
21.57
5.97
38.26%
BBNX
Beta Bionics, Inc.
19.73
2.28
13.07%
Concentra Group Holdings Parent, Inc. Corporate Events
Business Operations and StrategyExecutive/Board ChangesStock BuybackDividendsFinancial Disclosures
Concentra Raises 2026 Guidance After Strong Q2 Results
Positive
Aug 6, 2026
Concentra reported strong second-quarter 2026 results on August 6, 2026, with revenue up 10.0% to $606.0 million and net income rising 45.7% to $67.3 million. Adjusted EBITDA grew 22.5% to $140.9 million, supported by higher revenue per visit, inc...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.